Episode Details
Back to Episodes
Liraglutide Reduces BMI in Children, BridgeBio Halts Gene Therapy, Surge in Liver Disorder Cases, Vulcano's Surgery Offers Quick Relief, and more...
Published 1 year, 7 months ago
Description
(0:10): Breakthrough Study: Liraglutide Significantly Reduces BMI in Young Children, Sparks Debate on Safety and Approval
(2:09): BridgeBio Halts CAH Gene Therapy BBP-631, Shifts Focus to Promising Canavan Disease Treatment
(4:35): Global Surge in Liver Disorder: MASLD Prevalence Could Hit 46% by 2030, Innovations in Food Therapy Offer Hope
(6:48): Dr. Vulcano's Innovative Surgery Offers Rapid Relief for Achilles Tendinopathy Patients
(8:53): Study Reveals Higher Chronic Pain Risk from Abdominal Fat in Women, Urges Targeted Weight Management
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: PerthNow
(2:09): BridgeBio Halts CAH Gene Therapy BBP-631, Shifts Focus to Promising Canavan Disease Treatment
(4:35): Global Surge in Liver Disorder: MASLD Prevalence Could Hit 46% by 2030, Innovations in Food Therapy Offer Hope
(6:48): Dr. Vulcano's Innovative Surgery Offers Rapid Relief for Achilles Tendinopathy Patients
(8:53): Study Reveals Higher Chronic Pain Risk from Abdominal Fat in Women, Urges Targeted Weight Management
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: PerthNow